Table of Contents Table of Contents
Previous Page  25 / 83 Next Page
Information
Show Menu
Previous Page 25 / 83 Next Page
Page Background

**Draft meeting agenda is subject to change w/out notice

Version 2

AOAC INTERNATIONAL

Stakeholder Panel for Infant Formula and Adult Nutritionals (SPIFAN)

Meeting viaWeb/Teleconference at

AOAC INTERNATIONAL Headquarters

2275 Research Blvd. Suite 300, Rockville, MD 20850, USA

2- and 3-MCPD & GE WORKING GROUP

DRAFT MEETING AGENDA

Thursday, May 18, 2017

Meeting Start Time: 2:00PM (Eastern US)

Working Group Chair: Jan Kuhlmann

(

SGS Germany GmbH

)

This web conference will be held in accordance with AOAC policies for

Antitrust, Volunteer Conflict of Interest, and Use of Association Name and Insignia.

I.

INTRODUCTIONS/WELCOME (AOAC Staff/Kuhlmann – 2:00PM-2:05PM)

AOAC Staff will confirm participating attendees and Jan Kuhlmann (SGS Germany GmbH) will call the Working

Group meeting to order and welcome all participants.

II.

STANDARD METHOD PERFORMANCE REQUIREMENT (SMPR®) ORIENTATION/OVERVIEW (Coates –

2:05PM-2:15PM)

Scott Coates (AOAC) will provide the working group members with an overview of the SMPR® process.

III.

2- AND 3-MCPD AND GLYCIDYL ESTERS (GE) (Kuhlmann – 2:15PM-2:35PM)

Jan Kuhlmann will present the launch presentation including technical information, regulatory requirements,

and a proposed fitness for purpose for 2 and 3-monochloro-1,2-propanediol (2- and 3-MCPD) and glycidyl esters

(GE) in infant formula.

IV.

REVIEW OF ENDORSED FITNESS-FOR-PURPOSE

(Coates – 2:35PM-2:45PM)

Scott Coates will review the fitness-for-purpose statement approved by working group on March 15, 2017.

V.

STANDARD METHOD PERFORMANCE REQUIREMENT (SMPR®) DEVELOPMENT

(Kuhlmann/Coates –

2:45PM-3:25PM)

The working group led by Jan Kuhlmann and Scott Coates will begin drafting the SMPR®.

VI.

NEXT STEPS/WRAP UP

(AOAC Staff – 3:25PM-3:30PM)

AOAC Staff will review any action items for the working group and will provide a timeline of working group

activities, review of any action items, and answer additional questions.